Same-day Topamax appointment in California

If you’re struggling with Binge Eating Disorder (BED) and wondering whether you can access treatment online, you’re not alone. Telehealth has transformed mental health and eating disorder care, but the regulations around prescribing medications remotely can feel confusing—especially with all the headlines about changing telemedicine rules.

The short answer: Yes, you can legally receive medication for Binge Eating Disorder through telehealth in every U.S. state. The commonly prescribed medications for BED—like Topamax (topiramate) and Wellbutrin (bupropion)—are non-controlled substances, which means they aren’t subject to the strict federal telemedicine prescribing restrictions that apply to stimulants or opioids.

Let’s break down everything you need to know about getting BED treatment online in 2025 and 2026, including the legal landscape, who can prescribe, and what to expect from a quality telehealth provider.

Understanding Binge Eating Disorder and Why Medication Matters

Binge Eating Disorder is the most common eating disorder in the United States, yet it often goes undiagnosed and untreated. According to DSM-5 criteria, BED is characterized by:

• Recurrent episodes of eating large amounts of food within a discrete period (typically two hours)
• A sense of lack of control during these episodes
• Marked distress about binge eating
• Episodes occurring at least once a week for three months
• Eating behaviors that are not associated with compensatory behaviors like purging (which would indicate bulimia nervosa)

Unlike anorexia or bulimia, BED doesn’t involve purging, excessive exercise, or severe food restriction. However, it can lead to serious health complications including obesity, type 2 diabetes, cardiovascular disease, and significant psychological distress.

While the FDA has approved only one medication specifically for BED (lisdexamfetamine/Vyvanse, a controlled stimulant), several non-controlled medications have shown effectiveness in clinical studies and are commonly prescribed off-label. These include topiramate (Topamax) and bupropion (Wellbutrin)—both of which are fully accessible through legitimate telehealth platforms.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Legal Framework: Why Non-Controlled BED Medications Are Telehealth-Friendly

Federal Regulations

At the federal level, the Ryan Haight Act (2008) restricts telemedicine prescribing—but only for controlled substances (Schedule II-V drugs like Adderall, Xanax, or opioids). This law was designed to prevent online ‘pill mills’ from prescribing addictive medications without proper oversight.

Critically, the Ryan Haight Act does not apply to non-controlled medications. Topamax and Wellbutrin are not controlled substances, which means:

• No federal requirement for an in-person visit before prescribing
• No special DEA registration needed for telehealth prescribing
• Standard medical practice guidelines apply, just as they would in-person

During the COVID-19 public health emergency, the DEA temporarily relaxed even the controlled substance rules. Those flexibilities have been extended through December 31, 2026, allowing providers to prescribe certain controlled medications via telehealth without an initial in-person visit. However, for the BED medications we’re discussing, these extensions are largely irrelevant—they were never restricted in the first place.

State-by-State Variations

While federal law sets the baseline, each state has its own medical board regulations governing telehealth. The good news: most states have permanently adopted policies that support telehealth prescribing for non-controlled medications.

Here’s what varies by state:

States with No In-Person Requirement (Most Common)

• California, New York, Texas, Florida, Michigan, Wisconsin, Delaware, and many others allow providers to prescribe non-controlled medications after a telehealth evaluation that meets the standard of care
• California even explicitly allows asynchronous (questionnaire-based) evaluations if they’re clinically appropriate

States with Periodic In-Person Requirements

• Alabama requires an in-person visit within 12 months if you’ve had more than four telehealth visits for the same condition
• Georgia requires an annual in-person follow-up attempt for ongoing telemedicine care
• New Hampshire requires a follow-up in-person exam at least every 12 months for controlled substances only (not applicable to BED medications)

Even in these states, the initial prescription can still be issued via telehealth, and the periodic in-person visit can often be fulfilled by any collaborating provider—not necessarily your telehealth prescriber.

Who Can Prescribe BED Medications via Telehealth?

Physicians (MDs and DOs)

All licensed physicians can prescribe Topamax and Wellbutrin via telehealth in any state where they hold a medical license. This is straightforward and universally accepted.

Nurse Practitioners (NPs)

The landscape for NP prescribing has evolved dramatically in recent years. As of 2025:

• 34 states plus DC grant Nurse Practitioners Full Practice Authority (FPA), meaning they can evaluate patients and prescribe medications independently without physician oversight
• States that recently joined this list include Michigan (2025), Wisconsin (August 2025), and Louisiana (2024)
• In FPA states like California, New York, or New Hampshire, your NP can manage your entire BED treatment independently

In states without FPA (such as Texas, Florida, Georgia, and Alabama), NPs must work under a collaborative practice agreement with a physician. This doesn’t typically affect your care experience—the NP still conducts your evaluation and manages your treatment—but there’s formal physician oversight in the background.

Physician Assistants (PAs)

PAs can prescribe non-controlled medications in all states, but they universally require physician supervision or collaboration. The level of autonomy varies by state, but for practical purposes, a PA working with a telehealth platform can prescribe Topamax or Wellbutrin for BED in any state.

At Klarity Health: Transparent Access to BED Treatment

Klarity Health connects patients with licensed prescribers who can evaluate and treat Binge Eating Disorder via secure video visits. Our platform is designed with several patient-first principles:

• Provider availability across multiple states, so you can access care where you live
• Transparent, upfront pricing—you’ll know the cost before your appointment
• Both insurance and cash-pay options, making treatment accessible regardless of your coverage situation
• Licensed prescribers (MDs, DOs, NPs, and PAs) who specialize in mental health and eating disorders

Our providers follow all state and federal regulations, conduct thorough clinical evaluations, and create personalized treatment plans that may include medication, therapy referrals, and lifestyle guidance.

Medications Commonly Prescribed for BED via Telehealth

Topamax (Topiramate)

What it is: Originally FDA-approved for seizures and migraine prevention, topiramate is frequently prescribed off-label for BED.

How it works: Topiramate modulates neurotransmitters that may reduce impulsive eating behaviors and help regulate appetite.

Typical dosing: Usually started at a low dose (25mg) and gradually increased. Many patients see benefits at 75-200mg daily.

Key considerations:

• Pregnancy risk: Topiramate is associated with birth defects, including cleft palate. Women of childbearing age should use effective contraception
• Common side effects: Tingling in hands/feet, taste changes, cognitive effects (‘word-finding difficulties’), weight loss
• Contraindications: Use caution with kidney stones, glaucoma, or metabolic acidosis
• Monitoring: Regular follow-ups to assess cognitive effects, weight changes, and metabolic parameters

Telehealth access: Fully available via telehealth in all states. Providers can prescribe up to a 90-day supply with refills.

Wellbutrin (Bupropion)

What it is: FDA-approved for depression and smoking cessation, bupropion is used off-label for BED.

How it works: As an NDRI (norepinephrine-dopamine reuptake inhibitor), it may reduce binge frequency by modulating reward pathways and improving mood.

Typical dosing: Starting dose of 150mg once daily, may increase to 300-450mg (in divided doses for immediate-release formulations).

Key considerations:

• Major contraindication: Should not be used in patients with current or past bulimia or anorexia nervosa due to significantly increased seizure risk
• Seizure risk: Also elevated with alcohol withdrawal, head injury, or seizure disorders
• Black box warning: Like all antidepressants, carries a warning about increased suicidal thoughts in patients under age 25—close monitoring is essential
• Common side effects: Insomnia, dry mouth, headache, anxiety, increased blood pressure
• Monitoring: Mood monitoring, blood pressure checks, especially in first weeks

Telehealth access: Widely prescribed via telehealth. Providers can issue 90-day prescriptions with refills for up to one year.

What to Expect from a Telehealth BED Evaluation

A quality telehealth evaluation for Binge Eating Disorder should be comprehensive, typically lasting 30-60 minutes for an initial appointment. Here’s what legitimate providers will cover:

Clinical History

• Detailed questions about your eating patterns and behaviors
• Frequency and severity of binge episodes
• Triggers and emotional states associated with binges
• Impact on your daily functioning and quality of life
• History of other eating disorders or mental health conditions

Medical Screening

• Current medications and supplements
• Medical conditions (especially seizure history, cardiovascular issues, pregnancy status)
• Previous treatments attempted for BED
• Family history of eating disorders or psychiatric conditions
• Substance use, including alcohol

Diagnostic Assessment

• Verification that symptoms meet DSM-5 criteria for BED
• Ruling out other eating disorders (bulimia, anorexia with binge/purge subtype)
• Assessment for co-occurring conditions like depression, anxiety, or ADHD
• Sometimes standardized questionnaires like the Binge Eating Scale (BES)

Treatment Planning

• Discussion of medication options, including benefits and risks
• Explanation of off-label use where applicable
• Alternative treatments (therapy, nutrition counseling, support groups)
• Informed consent for telehealth and medication treatment
• Follow-up schedule and safety monitoring plan

Red Flags in Telehealth Services

Avoid providers who:

• Promise prescriptions before completing a thorough evaluation
• Conduct extremely brief consultations (under 15 minutes)
• Don’t discuss non-medication treatment options
• Fail to screen for contraindications
• Don’t require identity verification or informed consent
• Ship medications directly rather than using licensed pharmacies
• Guarantee specific medications before assessment

Safety Considerations and Monitoring

Who May Not Be Suitable for Telehealth BED Treatment

Telehealth is convenient and effective for many patients, but certain situations may require in-person care:

Absolute contraindications for these medications:

• History of anorexia or bulimia (for bupropion)
• Active seizure disorder (for bupropion)
• Pregnancy or inadequate contraception (for topiramate)
• Severe uncontrolled medical conditions requiring hands-on examination

Situations requiring in-person evaluation:

• Severe medical complications from BED (uncontrolled diabetes, cardiovascular instability)
• Suicidal ideation requiring immediate intervention
• Need for controlled substance treatment (Vyvanse for BED)
• Preference for comprehensive in-person eating disorder program
• Concurrent severe mental health conditions requiring intensive treatment

Ongoing Monitoring

Responsible telehealth providers will schedule regular follow-up appointments:

Typical follow-up schedule:

• 2-week check-in after starting medication (to assess tolerance and side effects)
• Monthly visits for the first 3 months
• Every 2-3 months thereafter if stable

What providers will monitor:

• Reduction in binge frequency and severity
• Side effects and medication tolerance
• Weight and metabolic parameters
• Mood and suicidal ideation (especially with bupropion)
• Compliance with contraception (for topiramate)
• Need for dose adjustments or treatment changes

Prescription Drug Monitoring Programs (PDMPs)

You might wonder whether your telehealth provider will check state prescription databases before prescribing BED medications.

The reality: Most states require PDMP checks only for controlled substances. Since Topamax and Wellbutrin are non-controlled:

• No legal requirement to check PDMP in most states
• However, many providers voluntarily review your medication history as good clinical practice
• This helps identify potential drug interactions and ensures you’re not receiving duplicate prescriptions

This is typically done through your self-reported medication list and, if needed, pharmacy records—not through mandatory database queries.

Insurance Coverage and Cost Considerations

Telehealth Coverage

Most insurance plans now cover telehealth visits at the same rate as in-person appointments, thanks to policies adopted during and after the COVID-19 pandemic. Many of these expanded telehealth benefits have been made permanent.

Medicare has extended telehealth flexibilities through 2026, though rules for mental health specifically may vary.

Private insurance typically covers telehealth for mental health and eating disorder treatment, but check your specific plan.

Medication Costs

Generic topiramate and bupropion are usually inexpensive:

• Generic topiramate: Often $10-30/month with insurance; $20-50 without
• Generic bupropion: Often $10-40/month with insurance; $30-70 without

Brand-name versions (Topamax, Wellbutrin) cost significantly more but are rarely necessary.

At Klarity Health, we accept both insurance and offer transparent cash-pay pricing, so cost shouldn’t be a barrier to getting the care you need.

Recent Regulatory Developments (2025-2026)

Federal Updates

The DEA has extended COVID-era telehealth prescribing flexibilities for controlled substances through December 31, 2026. While this doesn’t directly affect Topamax or Wellbutrin (which were never restricted), it signals continued federal support for telehealth access.

A permanent DEA rule on telehealth controlled substance prescribing is expected by late 2026. Patient advocates hope it will maintain flexibility while ensuring safety.

State Legislative Changes

New Hampshire (August 2025): Passed legislation explicitly allowing telehealth prescribing of Schedule II-IV controlled substances with an annual in-person follow-up requirement. This further normalizes telehealth prescribing overall.

Wisconsin (August 2025): Passed the APRN Modernization Act, granting Nurse Practitioners full practice authority. Wisconsin patients can now see NPs for BED treatment without physician oversight requirements.

Michigan (2025): Implemented full practice authority for NPs under 2023 legislation, expanding access to independent NP care.

New York (May 2025): Adopted rules requiring in-person exams before prescribing controlled substances (once federal waivers end), but this does not affect non-controlled medications like those used for BED.

California (2025): Amended telehealth law (AB 1503) to explicitly include asynchronous telemedicine as a valid ‘good faith exam’ for prescribing, further expanding access.

Comprehensive Treatment: Beyond Medication

While this guide focuses on medication access, effective BED treatment typically involves multiple approaches:

Evidence-Based Psychotherapy

Cognitive Behavioral Therapy (CBT) is considered the gold standard for BED treatment. It helps you:

• Identify triggers for binge eating
• Develop healthier coping strategies
• Challenge distorted thoughts about food, weight, and body image
• Establish regular eating patterns

Dialectical Behavior Therapy (DBT) can help with emotion regulation and distress tolerance.

Interpersonal Therapy (IPT) addresses relationship patterns that may contribute to disordered eating.

Many telehealth platforms, including Klarity Health, can connect you with therapists who specialize in eating disorders.

Nutritional Counseling

Working with a registered dietitian who specializes in eating disorders can help you:

• Develop a balanced, non-restrictive eating plan
• Reduce food rules and rigid thinking
• Practice intuitive eating principles
• Address nutritional deficiencies

Support Groups

Organizations like Overeaters Anonymous (OA) and the Binge Eating Disorder Association (BEDA) offer peer support, which many people find invaluable.

Medical Management

Since BED often co-occurs with metabolic conditions, working with a primary care provider to manage diabetes, hypertension, or other health issues is important.

The most effective approach combines medication with therapy and lifestyle changes. Telehealth makes it easier to access all these components of care.

How to Get Started with Telehealth for BED

Step 1: Research reputable providersLook for telehealth platforms that:

• Employ licensed prescribers in your state
• Conduct thorough evaluations (not 5-minute questionnaires)
• Are transparent about costs
• Have positive patient reviews and appropriate credentials
• Discuss both medication and non-medication treatment options

Step 2: Prepare for your appointment

• Write down your binge eating episodes (frequency, triggers, feelings)
• List current medications and medical conditions
• Note previous treatments you’ve tried
• Prepare questions about treatment options
• Have your insurance information ready (if applicable)

Step 3: Complete the evaluationBe honest and thorough in describing your symptoms. The provider can only help based on the information you share.

Step 4: Review your treatment planMake sure you understand:

• Why a specific medication is recommended
• Potential side effects and how to manage them
• What to expect in terms of symptom improvement
• Follow-up schedule
• When to contact the provider between appointments

Step 5: Fill your prescriptionLegitimate providers will send prescriptions to a licensed pharmacy of your choice—not ship pills directly to you.

Step 6: Attend follow-up appointmentsRegular monitoring is essential for safety and effectiveness. Don’t skip scheduled check-ins.

Why Telehealth Access Matters for BED Treatment

Binge Eating Disorder is often accompanied by shame, making it difficult for people to seek help. Telehealth removes several barriers:

Privacy and comfort: You can speak with a provider from your own home, which many find less intimidating than going to a clinic.

Access to specialists: Many areas lack eating disorder specialists. Telehealth connects you with experienced providers regardless of geography.

Scheduling flexibility: Evening and weekend appointments are often more available via telehealth.

Continuity of care: If you travel or move, you can potentially continue with the same provider (as long as they’re licensed in your new state).

Reduced stigma: For many people, the ability to access treatment discreetly is crucial to actually seeking help.

The Bottom Line

Getting medication for Binge Eating Disorder through telehealth is legal, safe, and effective when done through reputable providers who follow proper clinical protocols. The non-controlled medications commonly used for BED—topiramate (Topamax) and bupropion (Wellbutrin)—are fully accessible via telemedicine in all 50 states.

The telehealth landscape in 2025-2026 is stable and mature, with clear regulations, established safety protocols, and improved access compared to pre-pandemic times. While rules for controlled substances continue to evolve, patients seeking treatment for BED with non-controlled medications can access care confidently.

If you’re struggling with binge eating, don’t let uncertainty about telemedicine rules prevent you from seeking help. Effective treatment is available, accessible, and can make a profound difference in your quality of life.

Take the Next Step

If you’re ready to explore treatment for Binge Eating Disorder, Klarity Health offers convenient access to licensed providers who specialize in eating disorders and mental health. With transparent pricing, flexible scheduling, and both insurance and cash-pay options, we make it easy to get the care you deserve.

Schedule a confidential consultation today and take the first step toward a healthier relationship with food and yourself.

Frequently Asked Questions

Q: Do I need a referral to see a telehealth provider for BED?
A: No, most telehealth platforms allow you to schedule directly without a referral. However, check your insurance plan—some require referrals for specialist care.

Q: Can I get a prescription for Vyvanse (the FDA-approved BED medication) via telehealth?
A: This is more complicated. Vyvanse is a Schedule II controlled substance. While the current DEA extension allows telehealth prescribing through December 2026, many telehealth platforms choose not to prescribe stimulants remotely due to regulatory uncertainty and abuse potential. You may need an in-person visit for Vyvanse.

Q: What if I live in a state where my telehealth provider isn’t licensed?
A: Providers must be licensed in your state to treat you. Most multi-state platforms will verify your location and match you with an appropriately licensed provider.

Q: How long does it take to see results from BED medications?
A: This varies by individual and medication. Some people notice reduced binge urges within 2-4 weeks, while others may need 8-12 weeks at therapeutic doses to see significant improvement.

Q: Are these medications addictive?
A: No. Topiramate and bupropion are not controlled substances and do not have addiction potential. However, they should be tapered gradually when discontinuing to avoid withdrawal effects (especially topiramate).

Q: What if the medication doesn’t work for me?
A: Not everyone responds to the same medication. Your provider can adjust the dose, try a different medication, or focus more intensively on therapy and other interventions.

Research Currency Statement

Verified as of: January 4, 2026

• DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

• States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

• Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

• Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Citations

1. U.S. Department of Health and Human Services. (2026, January). DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026. Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. (2025, August). Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions. Retrieved from https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. (2025). Online Prescribing State-by-State Database. Retrieved from https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. (2025). State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025). Retrieved from https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. U.S. National Library of Medicine DailyMed. (2024). Bupropion Hydrochloride Extended-Release Tablets Label. Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

This article is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider for diagnosis and treatment recommendations specific to your situation.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12